Johns Hopkins ABX Guide
Sulfadoxine/Pyrimethamine
INDICATIONS
FDA
FDA
- No longer available in the U.S.
- Prophylaxis and treatment of chloroquine-resistant malaria.
- Malaria (acute) in combination with sulfadoxine and quinine in treating chloroquine-resistant Plasmodium falciparum malaria.
- Resistance is prevalent worldwide (not recommended as a prophylactic agent for travelers to most areas).
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: April 5, 2026
Citation
Auwaerter, Paul G. "Sulfadoxine/Pyrimethamine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540463/all/Sulfadoxine_Pyrimethamine.
Auwaerter PG. Sulfadoxine/Pyrimethamine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540463/all/Sulfadoxine_Pyrimethamine. Accessed April 9, 2026.
Auwaerter, P. G. (2026). Sulfadoxine/Pyrimethamine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540463/all/Sulfadoxine_Pyrimethamine
Auwaerter PG. Sulfadoxine/Pyrimethamine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. [cited 2026 April 09]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540463/all/Sulfadoxine_Pyrimethamine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sulfadoxine/Pyrimethamine
ID - 540463
A1 - Auwaerter,Paul,M.D.
Y1 - 2026/04/05/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540463/all/Sulfadoxine_Pyrimethamine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
